{
  "Cancer Histology Type (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        914, 
        922
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        956, 
        970
      ]
    }
  ], 
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        749, 
        772
      ]
    }
  ], 
  "Comments Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1145, 
        1165
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        809, 
        836
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        521, 
        550
      ]
    }
  ], 
  "Microscopic Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1023, 
        1058
      ]
    }
  ], 
  "Nature of Specimen Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1100, 
        1126
      ]
    }
  ], 
  "Neoplasm Behaviour (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        904, 
        913
      ]
    }
  ], 
  "Neoplasm Descriptive Grade (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        882, 
        903
      ]
    }
  ], 
  "Neoplasm Grade-Score Name (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        984, 
        991
      ]
    }
  ], 
  "Neoplasm Score Value (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1004, 
        1006
      ]
    }
  ], 
  "Organ/Body Structure (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        838, 
        845
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        974, 
        982
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1128, 
        1135
      ]
    }
  ], 
  "Positive Findings Phraseology (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        923, 
        938
      ]
    }
  ], 
  "__text": "MSH|^~\\&|PathSys|Methodist Medical Center (Oak Ridge)^44D0311996^CLIA|eMARCPlus|TN Cancer Registry|20170919125854||ORU^R01^ORU_R01|201709191258540001|P|2.5.1|TN||||||||VOL_V_40_ORU_R01-CCR1^NAACCR_CP\nOBR|1||17-OT-004703^PathSys^44D0311996^CLIA|11529-5^SURGICAL PATH REPORT^LN|||20170806000000|||||||20170807000000|&Urinary Bladder, Biopsy|1295977783^^^^^^MD^^CMS^D^^^NPI||||||20170809000000|||F||||||C67.9^Malignant neoplasm of bladder, unspecified^I10~C61^Malignant neoplasm of prostate^I10|1497721872&&&&&&&&CMS\n\n\n\n\n\n\n\nPath report.gross description\n\n\", bladder biopsy\": Received in formalin are 3 pieces of pale pink, friable tissue ranging from 0.6 cm to 1.4 cm in greatest dimension. The specimen is submitted completely in cassette 1A. (AKG)\n\n\nPath report.relevant Hx\n\nHistory - Clot urinary retention\n\n\nPath report.final diagnosis\n\nBladder biopsy (transurethral resection):   Poorly differentiated malignant neoplasm consistent with persistent       adenocarcinoma of prostate, Gleason grade 5+5 = 10. See Comment.\n\n\nPath report.microscopic examination\n\nMicroscopic examination is performed.\n\n\nPath report.site of origin\n\nBladder biopsy\n\n\nPath report.comments\n\nComments - Sections of the bladder biopsy demonstrate complete replacement of the tissues by sheets of a poorly differentiated malignant neoplasm. The tumor cells have hyperchromatic, pleomorphic nuclei. Focal necrosis is present. Immunohistochemical stains with appropriate controls are performed. The tumor cells show focal weakly positive staining for prostate specific antigen (PSA) and are negative for cytokeratin 5/6 and cytokeratin 20. Tumor nuclei are negative for p63. This patient has a history of biopsy proven high grade adenocarcinoma of the prostate, Gleason 10, which has been resistant to androgen deprivation therapy. In addition, he has a reported history of bladder cancer. No previous material, however, is available in this laboratory for review. The morphologic and immunohistochemical findings in the current biopsy material are consistent with persistent adenocarcinoma of the prostate, Gleason grade 5+5 = 10. The case has been reviewed by Dr. Janet Allen who concurs with the diagnosis.\n\n\n"
}